Deutsche Bank’s BELLUS Health Inc. BLU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,416
Closed -$39K 4040
2023
Q1
$39K Hold
5,416
﹤0.01% 3606
2022
Q4
$44.5K Buy
+5,416
New +$50.5K ﹤0.01% 3607
2022
Q3
Sell
-5,416
Closed -$50K 4114
2022
Q2
$50K Buy
+5,416
New +$44.3K ﹤0.01% 3757
2021
Q3
Sell
-97,782
Closed -$304K 4745
2021
Q2
$304K Buy
97,782
+89,882
+1,138% +$343K ﹤0.01% 3538
2021
Q1
$30K Sell
7,900
-37,357
-83% -$142K ﹤0.01% 4340
2020
Q4
$138K Sell
45,257
-34,550
-43% -$93.6K ﹤0.01% 3665
2020
Q3
$181K Sell
79,807
-6,114
-7% -$17.3K ﹤0.01% 3271
2020
Q2
$884K Buy
+85,921
New +$871K ﹤0.01% 2305
2020
Q1
Sell
-8,629
Closed -$65K 4977
2019
Q4
$65K Buy
8,629
+8,529
+8,529% +$58.3K ﹤0.01% 3826
2019
Q3
$0 Buy
+100
New +$706 ﹤0.01% 5384

Other funds holding BLU

Deutsche Bank's BLU Position: Q2 2023 in Review

Deutsche Bank sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 5,416 shares — an estimated $39K sold.

Deutsche Bank first reported a position in BLU in Q3 2019 and held it in 10 quarters. The position peaked at $884K in Q2 2020. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • Deutsche Bank reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • Deutsche Bank sold 5,416 BELLUS Health Inc. shares in Q2 2023, an estimated $39K.
  • Deutsche Bank first reported a position in BELLUS Health Inc. in Q3 2019 and held it in 10 quarters.
  • Deutsche Bank's BELLUS Health Inc. position peaked at $884K in Q2 2020.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Deutsche Bank's 13F filing for Q2 2023, filed 14 Aug 2023.